The U.S. Food and Drugs Administration has approved Remdesivir antiviral from the pharmaceutical company Gilead as a treatment to treat Covid.
Bloomberg agency and CNBC report it.
Remdesivir was already used in American hospitals after the FDA had guaranteed its use in an emergency in May, although not formally approved.
Now it becomes the first officially approved antiviral treatment in the US.
It will be used for infected patients forced to be hospitalized.